These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 14571005)

  • 1. Nadroparin plus aspirin versus aspirin alone in the treatment of acute ischemic stroke.
    Sarma GR; Roy AK
    Neurol India; 2003 Jun; 51(2):208-10. PubMed ID: 14571005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study.
    Wong KS; Chen C; Ng PW; Tsoi TH; Li HL; Fong WC; Yeung J; Wong CK; Yip KK; Gao H; Wong HB;
    Lancet Neurol; 2007 May; 6(5):407-13. PubMed ID: 17434095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.
    Kaandorp SP; Goddijn M; van der Post JA; Hutten BA; Verhoeve HR; Hamulyák K; Mol BW; Folkeringa N; Nahuis M; Papatsonis DN; Büller HR; van der Veen F; Middeldorp S
    N Engl J Med; 2010 Apr; 362(17):1586-96. PubMed ID: 20335572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nadroparin in acute ischemic stroke.
    Kumar S
    Neurol India; 2004 Jun; 52(2):273-4. PubMed ID: 15269500
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-molecular-weight heparin and early neurologic deterioration in acute stroke caused by large artery occlusive disease.
    Wang Q; Chen C; Chen XY; Han JH; Soo Y; Leung TW; Mok V; Wong KS
    Arch Neurol; 2012 Nov; 69(11):1454-60. PubMed ID: 22893265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-molecular-weight heparin versus aspirin for acute ischemic stroke with large artery occlusive disease: subgroup analyses from the Fraxiparin in Stroke Study for the treatment of ischemic stroke (FISS-tris) study.
    Wang QS; Chen C; Chen XY; Han JH; Soo Y; Leung TW; Mok V; Wong KS
    Stroke; 2012 Feb; 43(2):346-9. PubMed ID: 22076004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between aspirin combined with dipyridamole versus aspirin alone within 48 hours after ischemic stroke event for prevention of recurrent stroke and improvement of neurological function: a preliminary study.
    Chairangsarit P; Sithinamsuwan P; Niyasom S; Udommongkol C; Nidhinandana S; Suwantamee J
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S148-54. PubMed ID: 16858953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASA or low-molecular-weight heparin in the initial management of acute ischemic stroke complicating atrial fibrillation?
    Farquhar D
    CMAJ; 2001 Feb; 164(3):396. PubMed ID: 11232150
    [No Abstract]   [Full Text] [Related]  

  • 9. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
    Sztriha LK; Vécsei L
    Ideggyogy Sz; 2008 May; 61(5-6):148-54. PubMed ID: 18567389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet drugs for ischemic stroke prevention.
    Leys D; Balucani C; Cordonnier C
    Cerebrovasc Dis; 2009; 27 Suppl 1():120-5. PubMed ID: 19342841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin vs anticoagulation in carotid artery dissection: a study of 298 patients.
    Georgiadis D; Arnold M; von Buedingen HC; Valko P; Sarikaya H; Rousson V; Mattle HP; Bousser MG; Baumgartner RW
    Neurology; 2009 May; 72(21):1810-5. PubMed ID: 19321846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of low molecular weight heparin on survival in patients with advanced malignancy.
    Klerk CP; Smorenburg SM; Otten HM; Lensing AW; Prins MH; Piovella F; Prandoni P; Bos MM; Richel DJ; van Tienhoven G; Büller HR
    J Clin Oncol; 2005 Apr; 23(10):2130-5. PubMed ID: 15699479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjusted indirect meta-analysis of aspirin plus warfarin at international normalized ratios 2 to 3 versus aspirin plus clopidogrel after acute coronary syndromes.
    Testa L; Zoccai GB; Porto I; Trotta G; Agostoni P; Andreotti F; Crea F
    Am J Cardiol; 2007 Jun; 99(12):1637-42. PubMed ID: 17560866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
    Kamphuisen PW; Agnelli G
    Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-molecular-weight heparin is more effective than aspirin in preventing early neurologic deterioration and improving six-month outcome.
    Yi X; Lin J; Wang C; Zhang B; Chi W
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1537-44. PubMed ID: 24656240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
    Reaume KT; Regal RE; Dorsch MP
    Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triflusal and aspirin have different effects on inflammatory biomarkers measured in patients with acute ischemic stroke.
    Alvarez-Sabín J; Penalba A; Quintana M; Krupinski J; García-Bonilla L; Montaner J
    Cerebrovasc Dis; 2009; 28(4):371-7. PubMed ID: 19641312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low molecular weight heparin versus aspirin for acute ischemic stroke: a systematic review.
    Bath P; Leonardi-Bee J; Bath F
    J Stroke Cerebrovasc Dis; 2002; 11(2):55-62. PubMed ID: 17903857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fixed low-dose warfarin added to aspirin in the long term after acute myocardial infarction; the LoWASA Study.
    Herlitz J; Holm J; Peterson M; Karlson BW; Haglid Evander M; Erhardt L;
    Eur Heart J; 2004 Feb; 25(3):232-9. PubMed ID: 14972424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.